eNews

UBRELVY® – A First-In-Class Therapy for the Treatment of Migraines
Drug Review: Volume 23, Issue 6 – Download PDF Migraines are a class of debilitating headaches that reduce patients’ quality of life, work performance and

VRAYLAR® – A New Treatment Option for Schizophrenia & Bipolar I Disorder
Drug Review: Volume 23, Issue 5 – Download PDF Schizophrenia is a mental disorder characterized by a range of symptoms including psychosis (hallucinations, delusions, and

KORSUVA® – First Approved Drug for Chronic Kidney Disease-associated Pruritis
Drug Review: Volume 23, Issue 4 – Download PDF Chronic Kidney Disease (CKD) is the gradual and irreversible loss of kidney function over several months

Novel Treatment Options for Insomnia
Drug Review: Volume 23, Issue 3 – Download PDF Insomnia is a sleep disorder that is characterized by symptoms of difficulty initiating sleep, difficulty maintaining

KERENDIA® – A New Treatment for Chronic Kidney Disease Associated with Diabetes
Drug Review: Volume 23, Issue 2 – Download PDF Chronic Kidney Disease (CKD) is the gradual and irreversible loss of kidney function over several months

VABYSMO® – A New Treatment for Chronic Eye Conditions Related to Macular Edema
Drug Review: Volume 23, Issue 1 – Download PDF The macula is the part of the eye responsible for sharp, clear central vision. Macular edema

Breztri Aerosphere® – A New Triple Therapy Inhaler for COPD
Drug Review: Volume 22, Issue 12 – Download PDF Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airways. Limited

MYINFLA® – New Prevention Therapy for Cardiovascular Diseases
Drug Review: Volume 22, Issue 11 – Download PDF Cardiovascular diseases (CVDs), such as heart attack or stroke, are one of the leading causes of

Vulvovaginal Atrophy – Novel Treatment Options
Drug Review: Volume 22, Issue 10 – Download PDF Vulvovaginal atrophy (VVA) is the thinning, drying and inflammation of the vaginal wall caused by low